Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study
Background: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. Material and methods: From all patients in LIPIDOGRAM2015 Study (<i>n</i> = 13,72...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-09-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/19/4472 |
| _version_ | 1797516230908706816 |
|---|---|
| author | Beata Labuz-Roszak Maciej Banach Michal Skrzypek Adam Windak Tomasz Tomasik Miroslaw Mastej Maciej Tomaszewski Dimitri P. Mikhailidis Peter P. Toth Alberico Catapano Kausik K. Ray George Howard Gregory Y. H. Lip Fadi J. Charchar Naveed Sattar Bryan Williams Thomas M. MacDonald Peter Penson Jacek J. Jozwiak on behalf of the LIPIDOGRAM2015 Investigators |
| author_facet | Beata Labuz-Roszak Maciej Banach Michal Skrzypek Adam Windak Tomasz Tomasik Miroslaw Mastej Maciej Tomaszewski Dimitri P. Mikhailidis Peter P. Toth Alberico Catapano Kausik K. Ray George Howard Gregory Y. H. Lip Fadi J. Charchar Naveed Sattar Bryan Williams Thomas M. MacDonald Peter Penson Jacek J. Jozwiak on behalf of the LIPIDOGRAM2015 Investigators |
| author_sort | Beata Labuz-Roszak |
| collection | DOAJ |
| description | Background: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. Material and methods: From all patients in LIPIDOGRAM2015 Study (<i>n</i> = 13,724), 268 subjects had a history of ischaemic stroke and were included. Results: 165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment (<i>p</i> = 0.047 and <i>p</i> = 0.012, respectively). A history of atrial fibrillation, CHD, and previous myocardial infarction correlated with anticoagulant treatment (<i>p</i> = 0.001, <i>p</i> = 0.011, and <i>p</i> < 0.0001, respectively). Age, gender, time from stroke onset, place of residence, and level of education were not associated with antiplatelet or anticoagulant treatment. Only 31.7% of patients were engaged in regular physical activity, 62% used appropriate diet, and 13.6% were current smokers. Conclusions: In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke. |
| first_indexed | 2024-03-10T06:58:20Z |
| format | Article |
| id | doaj.art-d2168d200f334c4892fe0978844e7b7c |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T06:58:20Z |
| publishDate | 2021-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-d2168d200f334c4892fe0978844e7b7c2023-11-22T16:19:57ZengMDPI AGJournal of Clinical Medicine2077-03832021-09-011019447210.3390/jcm10194472Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 StudyBeata Labuz-Roszak0Maciej Banach1Michal Skrzypek2Adam Windak3Tomasz Tomasik4Miroslaw Mastej5Maciej Tomaszewski6Dimitri P. Mikhailidis7Peter P. Toth8Alberico Catapano9Kausik K. Ray10George Howard11Gregory Y. H. Lip12Fadi J. Charchar13Naveed Sattar14Bryan Williams15Thomas M. MacDonald16Peter Penson17Jacek J. Jozwiak18on behalf of the LIPIDOGRAM2015 Investigators Department of Neurology, Institute of Medical Sciences, University of Opole, 45-052 Opole, PolandPolish Mothers Memorial Hospital Research Institute, 93-338 Lodz, PolandDepartment of Biostatistics, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, PolandDepartment of Family Medicine, Jagiellonian University Medical College, 31-061 Krakow, PolandDepartment of Family Medicine, Jagiellonian University Medical College, 31-061 Krakow, PolandMastej Medical Center, 38-200 Jasło, PolandDivision of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UKDepartment of Clinical Biochemistry, Royal Free Hospital, University College London, London NW3 2QG, UKCicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Pharmacological Sciences, University of Milano and Multimedica IRCCS, 20099 Milano, ItalyDepartment of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College, Kensington, London W6 8RP, UKDepartment of Biostatistics, School of Public Health of Alabama at Birmingham, Birmingham B15 2TT, UKLiverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool L14 3PE, UKSchool of Health and Life Sciences, Federation University Australia, Ballarat, VIC 3350, AustraliaInstitute of Cardiovascular and Medical Science, University of Glasgow, Glasgow G12 8TA, UKNIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London NW1 2BU, UKMEMO Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UKSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L2 2QP, UKDepartment of Family Medicine and Public Health, Institute of Medical Sciences, University of Opole, 45-052 Opole, PolandBackground: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. Material and methods: From all patients in LIPIDOGRAM2015 Study (<i>n</i> = 13,724), 268 subjects had a history of ischaemic stroke and were included. Results: 165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment (<i>p</i> = 0.047 and <i>p</i> = 0.012, respectively). A history of atrial fibrillation, CHD, and previous myocardial infarction correlated with anticoagulant treatment (<i>p</i> = 0.001, <i>p</i> = 0.011, and <i>p</i> < 0.0001, respectively). Age, gender, time from stroke onset, place of residence, and level of education were not associated with antiplatelet or anticoagulant treatment. Only 31.7% of patients were engaged in regular physical activity, 62% used appropriate diet, and 13.6% were current smokers. Conclusions: In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke.https://www.mdpi.com/2077-0383/10/19/4472secondary stroke preventionoral anticoagulant drugsoral antiplatelet drugsprimary health care |
| spellingShingle | Beata Labuz-Roszak Maciej Banach Michal Skrzypek Adam Windak Tomasz Tomasik Miroslaw Mastej Maciej Tomaszewski Dimitri P. Mikhailidis Peter P. Toth Alberico Catapano Kausik K. Ray George Howard Gregory Y. H. Lip Fadi J. Charchar Naveed Sattar Bryan Williams Thomas M. MacDonald Peter Penson Jacek J. Jozwiak on behalf of the LIPIDOGRAM2015 Investigators Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study Journal of Clinical Medicine secondary stroke prevention oral anticoagulant drugs oral antiplatelet drugs primary health care |
| title | Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study |
| title_full | Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study |
| title_fullStr | Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study |
| title_full_unstemmed | Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study |
| title_short | Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study |
| title_sort | secondary stroke prevention in polish adults results from the lipidogram2015 study |
| topic | secondary stroke prevention oral anticoagulant drugs oral antiplatelet drugs primary health care |
| url | https://www.mdpi.com/2077-0383/10/19/4472 |
| work_keys_str_mv | AT beatalabuzroszak secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT maciejbanach secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT michalskrzypek secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT adamwindak secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT tomasztomasik secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT miroslawmastej secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT maciejtomaszewski secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT dimitripmikhailidis secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT peterptoth secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT albericocatapano secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT kausikkray secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT georgehoward secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT gregoryyhlip secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT fadijcharchar secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT naveedsattar secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT bryanwilliams secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT thomasmmacdonald secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT peterpenson secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT jacekjjozwiak secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study AT onbehalfofthelipidogram2015investigators secondarystrokepreventioninpolishadultsresultsfromthelipidogram2015study |